XML 22 R16.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Accrued Expenses and Other Current Liabilities | 3 Months Ended
--- | ---
Mar. 31, 2024
Payables and Accruals [Abstract] |
Accrued Expenses and Other Current Liabilities | 9. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands):
|  | March 31, 2024 |  |  | December 31, 2023 |
Accrued clinical study and trial costs |  | $ | 18,110 |  |  | $ | 16,346 |
Accrued compensation and related costs |  |  | 4,567 |  |  |  | 11,172 |
Accrued professional fees |  |  | 1,642 |  |  |  | 1,450 |
Accrued milestone costs |  |  | 8,000 |  |  |  | 10,000 |
Other |  |  | 1,076 |  |  |  | 888 |
Total accrued expenses and other current liabilities |  | $ | 33,395 |  |  | $ | 39,856 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration